1. Home
  2. RPRX
  3. RPRX News

Latest Royalty Pharma plc (RPRX) News on June 10, 2025

RPRX Q1 Earnings Call: Flat Revenue, Portfolio Expansion, and Capital Return Initiatives
RPRX

StockStory

a day ago

RPRX Q1 Earnings Call: Flat Revenue, Portfolio Expansion, and Capital Return Initiatives

Royalty Pharma to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
RPRX

GlobeNewswire

6 days ago

Royalty Pharma to Present at the Goldman Sachs 46th Annual Global Healthcare Conference

Royalty Pharma plc (NASDAQ:RPRX) On An Uptrend: Could Fundamentals Be Driving The Stock?
RPRX

Simply Wall St.

8 days ago

Royalty Pharma plc (NASDAQ:RPRX) On An Uptrend: Could Fundamentals Be Driving The Stock?

Royalty Pharma Completes the Acquisition of Its External Manager
RPRX

GlobeNewswire

25 days ago

Royalty Pharma Completes the Acquisition of Its External Manager

Royalty Pharma to Present at Upcoming Investor Conferences
RPRX

GlobeNewswire

a month ago

Royalty Pharma to Present at Upcoming Investor Conferences

Royalty Pharma Announces Shareholder Approval of its External Manager Acquisition
RPRX

GlobeNewswire

a month ago

Royalty Pharma Announces Shareholder Approval of its External Manager Acquisition

RPRX

Morningstar Research

a month ago

Analyst Report: Royalty Pharma plc

Royalty Pharma (NASDAQ:RPRX) Posts Q1 Sales In Line With Estimates
RPRX

StockStory

a month ago

Royalty Pharma (NASDAQ:RPRX) Posts Q1 Sales In Line With Estimates

Royalty Pharma Reports First Quarter 2025 Results
RPRX

GlobeNewswire

a month ago

Royalty Pharma Reports First Quarter 2025 Results

Royalty Pharma (RPRX) Reports Q1: Everything You Need To Know Ahead Of Earnings
RPRX

StockStory

a month ago

Royalty Pharma (RPRX) Reports Q1: Everything You Need To Know Ahead Of Earnings

Royalty Pharma (NasdaqGS:RPRX) Declares US$0.22 Dividend for Q2 2025
RPRX

Simply Wall St.

2 months ago

Royalty Pharma (NasdaqGS:RPRX) Declares US$0.22 Dividend for Q2 2025

Royalty Pharma Declares Second Quarter 2025 Dividend
RPRX

GlobeNewswire

2 months ago

Royalty Pharma Declares Second Quarter 2025 Dividend

Royalty Pharma to Announce First Quarter 2025 Financial Results on May 8, 2025
RPRX

GlobeNewswire

2 months ago

Royalty Pharma to Announce First Quarter 2025 Financial Results on May 8, 2025

Royalty Pharma Appoints Vlad Coric, M.D. to the Company’s Board of Directors
RPRX

GlobeNewswire

2 months ago

Royalty Pharma Appoints Vlad Coric, M.D. to the Company’s Board of Directors

Royalty Pharma Announces Upcoming Investor Day
RPRX

GlobeNewswire

2 months ago

Royalty Pharma Announces Upcoming Investor Day

Is Royalty Pharma plc (RPRX) The Best Defensive Stock Amid Market Volatility?
RPRX

Insider Monkey

3 months ago

Is Royalty Pharma plc (RPRX) The Best Defensive Stock Amid Market Volatility?

Royalty Pharma to Present at TD Cowen’s 45th Annual Health Care Conference
RPRX

GlobeNewswire

3 months ago

Royalty Pharma to Present at TD Cowen’s 45th Annual Health Care Conference

Why Royalty Pharma Plc (RPRX) is the Best Performing Pharma Stock So Far in 2025
RPRX

Insider Monkey

4 months ago

Why Royalty Pharma Plc (RPRX) is the Best Performing Pharma Stock So Far in 2025

RPRX

Morningstar Research

4 months ago

Analyst Report: Royalty Pharma plc

RPRX

Morningstar Research

4 months ago

Analyst Report: Royalty Pharma plc

Royalty Pharma Announces R&D Funding Collaboration With Biogen
RPRX

GlobeNewswire

4 months ago

Royalty Pharma Announces R&D Funding Collaboration With Biogen

RPRX

GuruFocus.com

4 months ago

Royalty Pharma PLC (RPRX) Q4 2024 Earnings Call Highlights: Strong Financial Performance and ...

Royalty Pharma (NASDAQ:RPRX) Misses Q4 Revenue Estimates
RPRX

StockStory

4 months ago

Royalty Pharma (NASDAQ:RPRX) Misses Q4 Revenue Estimates

Royalty Pharma Reports Q4 and Full Year 2024 Results
RPRX

GlobeNewswire

4 months ago

Royalty Pharma Reports Q4 and Full Year 2024 Results

Royalty Pharma Earnings: What To Look For From RPRX
RPRX

StockStory

4 months ago

Royalty Pharma Earnings: What To Look For From RPRX

Is Now The Time To Put Royalty Pharma (NASDAQ:RPRX) On Your Watchlist?
RPRX

Simply Wall St.

4 months ago

Is Now The Time To Put Royalty Pharma (NASDAQ:RPRX) On Your Watchlist?

Royalty Pharma Announces Sale of MorphoSys Development Funding Bonds
RPRX

GlobeNewswire

4 months ago

Royalty Pharma Announces Sale of MorphoSys Development Funding Bonds

Royalty Pharma to Announce Fourth Quarter and Full Year 2024 Financial Results on February 11, 2025
RPRX

GlobeNewswire

4 months ago

Royalty Pharma to Announce Fourth Quarter and Full Year 2024 Financial Results on February 11, 2025

Why Is Andreas Halvorsen Bullish On Royalty Pharma plc (RPRX) Now?
RPRX

Insider Monkey

5 months ago

Why Is Andreas Halvorsen Bullish On Royalty Pharma plc (RPRX) Now?

Royalty Pharma plc (RPRX): Analysts Recommend This 52-Week High Stocks Now
RPRX

Insider Monkey

5 months ago

Royalty Pharma plc (RPRX): Analysts Recommend This 52-Week High Stocks Now

Royalty Pharma (NASDAQ:RPRX) Has Announced That It Will Be Increasing Its Dividend To $0.22
RPRX

Simply Wall St.

5 months ago

Royalty Pharma (NASDAQ:RPRX) Has Announced That It Will Be Increasing Its Dividend To $0.22

Here’s Why Royalty Pharma plc (RPRX) Led This Week’s Rally
RPRX

Insider Monkey

5 months ago

Here’s Why Royalty Pharma plc (RPRX) Led This Week’s Rally

Did Royalty Pharma (RPRX) Close Shortened Trading Week Higher?
RPRX

Insider Monkey

5 months ago

Did Royalty Pharma (RPRX) Close Shortened Trading Week Higher?

Royalty Pharma to Highlight Accomplishments and Provide Business Update at 43rd Annual J.P. Morgan Healthcare Conference
RPRX

GlobeNewswire

5 months ago

Royalty Pharma to Highlight Accomplishments and Provide Business Update at 43rd Annual J.P. Morgan Healthcare Conference

Royalty Pharma Announces Transformative Step in Company’s Evolution With Acquisition of its External Manager and $3 Billion Share Repurchase Program
RPRX

GlobeNewswire

5 months ago

Royalty Pharma Announces Transformative Step in Company’s Evolution With Acquisition of its External Manager and $3 Billion Share Repurchase Program

Royalty Pharma Announces Dividend Increase
RPRX

GlobeNewswire

5 months ago

Royalty Pharma Announces Dividend Increase

Jim Cramer on Royalty Pharma plc (RPRX): ‘Disappointing Stock, Man, I Can’t Believe It’
RPRX

Insider Monkey

5 months ago

Jim Cramer on Royalty Pharma plc (RPRX): ‘Disappointing Stock, Man, I Can’t Believe It’

Royalty Pharma plc (NASDAQ:RPRX) is favoured by institutional owners who hold 72% of the company
RPRX

Simply Wall St.

6 months ago

Royalty Pharma plc (NASDAQ:RPRX) is favoured by institutional owners who hold 72% of the company

Jim Cramer Calls Royalty Pharma (RPRX) ‘Disappointing’ But Recommends Holding – ‘I Want You To Stick With It’
RPRX

Insider Monkey

6 months ago

Jim Cramer Calls Royalty Pharma (RPRX) ‘Disappointing’ But Recommends Holding – ‘I Want You To Stick With It’

Royalty Pharma to Present at Upcoming Investor Conferences
RPRX

GlobeNewswire

6 months ago

Royalty Pharma to Present at Upcoming Investor Conferences

Why Royalty Pharma (RPRX) is the Cheapest Stock to Buy on Robinhood?
RPRX

Insider Monkey

6 months ago

Why Royalty Pharma (RPRX) is the Cheapest Stock to Buy on Robinhood?

Royalty Pharma Announces Inaugural Prize for Impact in Healthcare
RPRX

GlobeNewswire

7 months ago

Royalty Pharma Announces Inaugural Prize for Impact in Healthcare

Royalty Pharma's (NASDAQ:RPRX) Profits May Not Reveal Underlying Issues
RPRX

Simply Wall St.

7 months ago

Royalty Pharma's (NASDAQ:RPRX) Profits May Not Reveal Underlying Issues

Royalty Pharma to Acquire Royalty Interest in Geron’s RYTELO for $125 Million
RPRX

GlobeNewswire

7 months ago

Royalty Pharma to Acquire Royalty Interest in Geron’s RYTELO for $125 Million

RPRX

GuruFocus.com

7 months ago

Royalty Pharma PLC (RPRX) Q3 2024 Earnings Call Highlights: Strong Growth and Strategic Acquisitions

Royalty Pharma PLC (RPRX): A Strategic SWOT Insight
RPRX

GuruFocus.com

7 months ago

Royalty Pharma PLC (RPRX): A Strategic SWOT Insight

RPRX

Morningstar Research

7 months ago

Analyst Report: Royalty Pharma plc

Royalty Pharma Reports Third Quarter 2024 Results
RPRX

GlobeNewswire

7 months ago

Royalty Pharma Reports Third Quarter 2024 Results

Royalty Pharma and Syndax Pharmaceuticals Enter Into $350 Million Royalty Funding Agreement for Niktimvo
RPRX

GlobeNewswire

7 months ago

Royalty Pharma and Syndax Pharmaceuticals Enter Into $350 Million Royalty Funding Agreement for Niktimvo

Syndax Pharmaceuticals and Royalty Pharma Enter into $350 Million Royalty Funding Agreement for Niktimvo™
RPRX

PR Newswire

7 months ago

Syndax Pharmaceuticals and Royalty Pharma Enter into $350 Million Royalty Funding Agreement for Niktimvo™

Morgan Stanley Predicts Up to 670% Jump for These 2 ‘Strong Buy’ Stocks
RPRX

TipRanks

7 months ago

Morgan Stanley Predicts Up to 670% Jump for These 2 ‘Strong Buy’ Stocks

Royalty Pharma to Announce Third Quarter 2024 Financial Results on November 6, 2024
RPRX

GlobeNewswire

8 months ago

Royalty Pharma to Announce Third Quarter 2024 Financial Results on November 6, 2024

Royalty Pharma's (NASDAQ:RPRX) Dividend Will Be $0.21
RPRX

Simply Wall St.

8 months ago

Royalty Pharma's (NASDAQ:RPRX) Dividend Will Be $0.21

Royalty Pharma Declares Fourth Quarter 2024 Dividend
RPRX

GlobeNewswire

8 months ago

Royalty Pharma Declares Fourth Quarter 2024 Dividend

RPRX

GuruFocus.com

8 months ago

Royalty Pharma PLC (RPRX) Q2 2024 Earnings Call Highlights: Surpassing Growth Expectations and ...

Royalty Pharma plc (RPRX): Among The Stocks With Biggest Upside Potential According to Hedge Funds
RPRX

Insider Monkey

8 months ago

Royalty Pharma plc (RPRX): Among The Stocks With Biggest Upside Potential According to Hedge Funds

Royalty Pharma plc's (NASDAQ:RPRX) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue?
RPRX

Simply Wall St.

9 months ago

Royalty Pharma plc's (NASDAQ:RPRX) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue?

Royalty Pharma and Ascendis Pharma Enter Into $150 Million Royalty Funding Agreement
RPRX

GlobeNewswire

9 months ago

Royalty Pharma and Ascendis Pharma Enter Into $150 Million Royalty Funding Agreement

Ascendis Pharma and Royalty Pharma Enter into $150 Million Royalty Funding Agreement
RPRX

GlobeNewswire

9 months ago

Ascendis Pharma and Royalty Pharma Enter into $150 Million Royalty Funding Agreement

Royalty Pharma to Present at Morgan Stanley’s 22nd Annual Global Healthcare Conference
RPRX

GlobeNewswire

9 months ago

Royalty Pharma to Present at Morgan Stanley’s 22nd Annual Global Healthcare Conference

Jim Cramer on Royalty Pharma plc (NASDAQ:RPRX): It’s Been a ‘Bit of a Bust, I Feel Badly’
RPRX

Insider Monkey

9 months ago

Jim Cramer on Royalty Pharma plc (NASDAQ:RPRX): It’s Been a ‘Bit of a Bust, I Feel Badly’

Why Is Royalty Pharma plc (RPRX) the Best Defensive Stock to Buy Now?
RPRX

Insider Monkey

10 months ago

Why Is Royalty Pharma plc (RPRX) the Best Defensive Stock to Buy Now?

Royalty Pharma Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
RPRX

Simply Wall St.

10 months ago

Royalty Pharma Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Royalty Pharma PLC (RPRX): A Strategic SWOT Insight
RPRX

GuruFocus.com

10 months ago

Royalty Pharma PLC (RPRX): A Strategic SWOT Insight

RPRX

Morningstar Research

10 months ago

Analyst Report: Royalty Pharma plc

Royalty Pharma Reports Second Quarter 2024 Results
RPRX

GlobeNewswire

10 months ago

Royalty Pharma Reports Second Quarter 2024 Results

Royalty Pharma Appoints Molly Sawaya as Executive Vice President, Head of Human Capital
RPRX

GlobeNewswire

a year ago

Royalty Pharma Appoints Molly Sawaya as Executive Vice President, Head of Human Capital

Royalty Pharma (NASDAQ:RPRX) Is Due To Pay A Dividend Of $0.21
RPRX

Simply Wall St.

a year ago

Royalty Pharma (NASDAQ:RPRX) Is Due To Pay A Dividend Of $0.21

Royalty Pharma to Announce Second Quarter 2024 Financial Results on August 8, 2024
RPRX

GlobeNewswire

a year ago

Royalty Pharma to Announce Second Quarter 2024 Financial Results on August 8, 2024

Royalty Pharma Declares Third Quarter 2024 Dividend
RPRX

GlobeNewswire

a year ago

Royalty Pharma Declares Third Quarter 2024 Dividend

Is Royalty Pharma plc (RPRX) a Good Stock to Buy Now?
RPRX

Insider Monkey

a year ago

Is Royalty Pharma plc (RPRX) a Good Stock to Buy Now?

Royalty Pharma plc (NASDAQ:RPRX) is largely controlled by institutional shareholders who own 70% of the company
RPRX

Simply Wall St.

a year ago

Royalty Pharma plc (NASDAQ:RPRX) is largely controlled by institutional shareholders who own 70% of the company

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia
RPRX

Business Insider

a year ago

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia

The Best Woody Perfume For Women
RPRX

Insider Monkey

a year ago

The Best Woody Perfume For Women

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase
RPRX

Reuters

a year ago

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase

RPRX

Insider Monkey

a year ago

Best Date Night Fragrance in 2024

France's Macron calls snap legislative elections after EU poll blow
RPRX

AFP

a year ago

France's Macron calls snap legislative elections after EU poll blow

Dow Jones Futures Due; Apple AI Push, Fed Rate Outlook Lead 8 Big Market Events
RPRX

Investor's Business Daily

a year ago

Dow Jones Futures Due; Apple AI Push, Fed Rate Outlook Lead 8 Big Market Events

Toronto Pearson conducts annual full-scale emergency exercise
RPRX

CNW Group

a year ago

Toronto Pearson conducts annual full-scale emergency exercise

European Union Vote Delivers Shift to Right, in Blow to French and German Governments
RPRX

The Wall Street Journal

a year ago

European Union Vote Delivers Shift to Right, in Blow to French and German Governments

Royalty Pharma to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
RPRX

GlobeNewswire

a year ago

Royalty Pharma to Present at the Goldman Sachs 45th Annual Global Healthcare Conference

Royalty Pharma and Agios Pharmaceuticals Enter Into Vorasidenib Royalty Agreement for $905 Million
RPRX

GlobeNewswire

a year ago

Royalty Pharma and Agios Pharmaceuticals Enter Into Vorasidenib Royalty Agreement for $905 Million

Royalty Pharma and Cytokinetics Announce Expanded Strategic Funding Collaboration Totaling Up to $575 Million to Support Commercial Launch of Aficamten and to Advance R&D Pipeline
RPRX

GlobeNewswire

a year ago

Royalty Pharma and Cytokinetics Announce Expanded Strategic Funding Collaboration Totaling Up to $575 Million to Support Commercial Launch of Aficamten and to Advance R&D Pipeline

Cytokinetics and Royalty Pharma Announce Expanded Strategic Funding Collaboration Totaling Up to $575 Million to Support Commercial Launch of Aficamten and to Advance R&D Pipeline
RPRX

GlobeNewswire

a year ago

Cytokinetics and Royalty Pharma Announce Expanded Strategic Funding Collaboration Totaling Up to $575 Million to Support Commercial Launch of Aficamten and to Advance R&D Pipeline

Royalty Pharma to Present at Upcoming Investor Conferences
RPRX

GlobeNewswire

a year ago

Royalty Pharma to Present at Upcoming Investor Conferences

Here's What Analysts Are Forecasting For Royalty Pharma plc (NASDAQ:RPRX) After Its First-Quarter Results
RPRX

Simply Wall St.

a year ago

Here's What Analysts Are Forecasting For Royalty Pharma plc (NASDAQ:RPRX) After Its First-Quarter Results

Only Four Days Left To Cash In On Royalty Pharma's (NASDAQ:RPRX) Dividend
RPRX

Simply Wall St.

a year ago

Only Four Days Left To Cash In On Royalty Pharma's (NASDAQ:RPRX) Dividend

Royalty Pharma PLC (RPRX): A Strategic SWOT Insight
RPRX

GuruFocus.com

a year ago

Royalty Pharma PLC (RPRX): A Strategic SWOT Insight

RPRX

Morningstar Research

a year ago

Analyst Report: Royalty Pharma plc

Royalty Pharma Reports First Quarter 2024 Results
RPRX

GlobeNewswire

a year ago

Royalty Pharma Reports First Quarter 2024 Results

Royalty Pharma to Acquire Royalty Interest in Sanofi’s Frexalimab
RPRX

GlobeNewswire

a year ago

Royalty Pharma to Acquire Royalty Interest in Sanofi’s Frexalimab

Royalty Pharma's (NASDAQ:RPRX) Dividend Will Be $0.21
RPRX

Simply Wall St.

a year ago

Royalty Pharma's (NASDAQ:RPRX) Dividend Will Be $0.21

Royalty Pharma (NASDAQ:RPRX) Will Pay A Dividend Of $0.21
RPRX

Simply Wall St.

a year ago

Royalty Pharma (NASDAQ:RPRX) Will Pay A Dividend Of $0.21

Royalty Pharma to Announce First Quarter 2024 Financial Results on May 9, 2024
RPRX

GlobeNewswire

a year ago

Royalty Pharma to Announce First Quarter 2024 Financial Results on May 9, 2024

Royalty Pharma Declares Second Quarter 2024 Dividend
RPRX

GlobeNewswire

a year ago

Royalty Pharma Declares Second Quarter 2024 Dividend

Royalty Pharma plc's (NASDAQ:RPRX) Stock Has Shown A Decent Performance: Have Financials A Role To Play?
RPRX

Simply Wall St.

a year ago

Royalty Pharma plc's (NASDAQ:RPRX) Stock Has Shown A Decent Performance: Have Financials A Role To Play?

Royalty Pharma to Present at TD Cowen’s 44th Annual Health Care Conference
RPRX

GlobeNewswire

a year ago

Royalty Pharma to Present at TD Cowen’s 44th Annual Health Care Conference

RPRX

Morningstar Research

a year ago

Morningstar | A Weekly Summary of Stock Ideas and Developments in the Companies We Cover

Analysts Have Made A Financial Statement On Royalty Pharma plc's (NASDAQ:RPRX) Yearly Report
RPRX

Simply Wall St.

a year ago

Analysts Have Made A Financial Statement On Royalty Pharma plc's (NASDAQ:RPRX) Yearly Report

Royalty Pharma Full Year 2023 Earnings: EPS: US$2.54 (vs US$0.098 in FY 2022)
RPRX

Simply Wall St.

a year ago

Royalty Pharma Full Year 2023 Earnings: EPS: US$2.54 (vs US$0.098 in FY 2022)

Share on Social Networks: